tiprankstipranks
Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market
Holding CYCN?
Track your performance easily

Cyclerion Therapeutics (CYCN) Stock News & Sentiment

203 Followers
Cyclerion Therapeutics Secures Funding and Expands CNS Focus
Premium
Company Announcements
Cyclerion Therapeutics Secures Funding and Expands CNS Focus
5d ago
Cyclerion Therapeutics ( ($CYCN) ) has provided an announcement. Cyclerion Therapeutics has renegotiated its praliciguat license agreement with Akebia, securing $1.75 million in upfront and near-term payments while reducing operating ...Read more
Cyclerion Therapeutics Appoints New CEO Regina Graul
Premium
Company Announcements
Cyclerion Therapeutics Appoints New CEO Regina Graul
5M ago

CYCN News on the Web

News Score - Last 7 Days

Neutral
CYCN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average65%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CYCN’s Media Buzz Sentiment?
1 articles about CYCN were published this week. In an average week, 1 articles are published.
    What is CYCN’s weekly average amount of articles?
    In an average week, 1 articles about CYCN are published.
      What is CYCN’s News Sentiment?
      50% of articles about CYCN were positive this week, compared to its sector average of 65%.
        Healthcare Stocks that are Trending in the News
        VRDNViridian Therapeutics
        ANNXAnnexon Biosciences
        LRMRLarimar Therapeutics
        MCKMcKesson
        TEVATeva Pharmaceutical
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis